The big problematic of modern medicine is to develop a new material with the properties to mimic the human tissue, from point of view architecture and chemical composition, in order to minimize the risk of rejection by the human body. In 2002, The American Association of Orthopedic Surgeons published a report, that indicate that bone implants are one of the most common transplants, outclassed by blood transfusions. To solve this problem, researchers' community was focused on getting a new class and improved materials with special properties for hard tissue replacement implants. For this objective, the field of biomaterials was explored [1], the biomaterials device market has increased relatively to two main categories of orthopaedic biomaterials: implants usually made of metals, ceramics, or hard polymers and scaffolds for bone tissue regeneration [2] . The second category of biomaterials is centred on biodegradable polymers and their composites [2] . The most frequently used biomaterial in orthopedic surgeries is hydroxyapatite (HA).
